Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
Top Cited Papers
- 15 October 2004
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 104 (8), 2224-2234
- https://doi.org/10.1182/blood-2004-03-1109
Abstract
The mechanisms responsible for recruiting monocytes from the bloodstream into solid tumors are now well characterized. However, recent evidence has shown that these cells then differentiate into macrophages and accumulate in large numbers in avascular and necrotic areas where they are exposed to hypoxia. This parallels their tendency to congregate in ischemic areas of other diseased tissues such as atherosclerotic plaques and arthritic joints. In tumors, macrophages appear to undergo marked phenotypic changes when exposed to hypoxia and to switch on their expression of a number of mitogenic and proangiogenic cytokines and enzymes. This then promotes tumor growth, angiogenesis, and metastasis. Here, we compare the various mechanisms responsible for monocyte recruitment into tumors with those regulating the accumulation of macrophages in hypoxic/necrotic areas. Because the latter are best characterized in human tumors, we focus mainly on these but also discuss their relevance to macrophage migration in ischemic areas of other diseased tissues. Finally, we discuss the relevance of these mechanisms to the development of novel cancer therapies, both in providing targets to reduce the proangiogenic contribution made by hypoxic macrophages in tumors and in developing the use of macrophages to deliver therapeutic gene constructs to hypoxic areas of diseased tissues.Keywords
This publication has 139 references indexed in Scilit:
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma CellsJournal of Biological Chemistry, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in miceGene Therapy, 2001
- Transfer of Heme Oxygenase 1 cDNA by a Replication-Deficient Adenovirus Enhances Interleukin 10 Production from Alveolar Macrophages That Attenuates Lipopolysaccharide-Induced Acute Lung Injury in MiceHuman Gene Therapy, 2001
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998
- Reduced expression of the CXC chemokine hIRH/SDF-1α mRNA in hepatoma and digestive tract cancerInternational Journal of Cancer, 1997
- Loss of hIRH mRNA Expression from Premalignant Adenomas and Malignant Cell LinesBiochemical and Biophysical Research Communications, 1996
- Macrophage colony‐stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppressionEuropean Journal of Immunology, 1993
- Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effectsCancer Immunology, Immunotherapy, 1991